Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-15
2006-08-15
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800, C530S356000, C530S407000, C530S412000, C435S212000, C435S273000, C424S548000
Reexamination Certificate
active
07091180
ABSTRACT:
Hydrolyzed collagen type II powder compositions for inducing cartilage formation in an individual, method of preparing the compositions and use of the compositions in treating connective tissue disorder, replenishing skin viscoelasticity. The compositions are administered through an orally ingestible delivery medium for absorption into the gastrointestinal tract. The compositions are administered through a topical delivery medium for absorption into a dermis of the individual.
REFERENCES:
patent: 4511653 (1985-04-01), Play et al.
patent: 4804745 (1989-02-01), Koepff et al.
patent: 5206023 (1993-04-01), Hunziker
patent: 5364775 (1994-11-01), Katsumata et al.
patent: 5364845 (1994-11-01), Henderson
patent: 5399347 (1995-03-01), Trentham et al.
patent: 5587363 (1996-12-01), Henderson
patent: 5645851 (1997-07-01), Moore
patent: 5840848 (1998-11-01), Sturrock et al.
patent: 6025327 (2000-02-01), Alkayali
patent: 6323319 (2001-11-01), Alkayali
patent: 6780841 (2004-08-01), Ishaq
patent: WO 97 25435 (1997-07-01), None
BIOCELL Technologies Website, http://www.biocelltechnology.com/press1.htm.
BIOCELL Technologies Website, http://www.biocelltechnology.com/ourproduct.htm.
Barinaga, Marcia Treating Arthritis with Tolerance. Science 361. 1669-1670 (1983).*
Bendi et al. Purification and Characterization of a Collagen-degrading Protease fromPorphyromonas gingivalisJ. Bic. Chem. 269:599-606 (1994).*
Bruckner et al. p-HMW-Collagen, a minor collagen obtained from chick embryo cartilage without proteolytic treatment of the tissue. Eur. J. Biochem. 136:333-339.*
Cremer et al. Collagen-Induced Arthritis in Rats: Antigen-specific Suppression of Arthritis and Immunity by Intraveneously Injected Native Type II Collagen. J. of Immun. 131 (6) 2995-3000 (1983.*
Darnell et al. Molecular Cell Biology. Scientific American Books, Inc. New York, NY 1985.*
Englert et al., Suppression of Type II Collagen-Induced Arthritis by th elntraveneous Administration of Type II Collagen or its Constituent Peptide (II) CB Cellular Immunology 87:357-365 (1984).*
Fawcett. A Textbook of Histology. W.B. Saunders Co. Philadelphia, PA (1986).*
Knauper et al. Biochemical Characterization of Human Collagenase-3. J. Biol. Chem. 271: 1544-1550 (1996).*
New Product Advertisement for “Hydrolyzed Collagen Beauty Supplement”. Smarter Nails & Hair, Inc. Newport Beach, CA 92660 (1987).*
Stryer. Collagen Has an Unusual Amino Acid Composition and Sequence. Biochemistry, Third Edition, W.H. Freeman and Co., New York, p. 262 (1988).*
Intellipi, LLC
Rutan & Tucker LLP
Witz Jean C.
LandOfFree
Hyaluronic acid and chondroitin sulfate based hydrolyzed... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hyaluronic acid and chondroitin sulfate based hydrolyzed..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyaluronic acid and chondroitin sulfate based hydrolyzed... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3654183